Innovative Eyewear (NASDAQ:LUCY – Get Free Report) and SiBone (NASDAQ:SIBN – Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, earnings, analyst recommendations, institutional ownership, profitability, dividends and valuation.
Profitability
This table compares Innovative Eyewear and SiBone’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Innovative Eyewear | -225.26% | -88.90% | -80.34% |
| SiBone | -6.85% | -8.23% | -6.07% |
Insider & Institutional Ownership
1.0% of Innovative Eyewear shares are owned by institutional investors. Comparatively, 98.1% of SiBone shares are owned by institutional investors. 1.7% of Innovative Eyewear shares are owned by insiders. Comparatively, 4.0% of SiBone shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Valuation and Earnings
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Innovative Eyewear | $2.66 million | 2.73 | -$7.59 million | ($1.29) | -0.65 |
| SiBone | $200.93 million | 4.04 | -$18.90 million | ($0.34) | -53.82 |
Innovative Eyewear has higher earnings, but lower revenue than SiBone. SiBone is trading at a lower price-to-earnings ratio than Innovative Eyewear, indicating that it is currently the more affordable of the two stocks.
Risk and Volatility
Innovative Eyewear has a beta of 2.76, indicating that its stock price is 176% more volatile than the S&P 500. Comparatively, SiBone has a beta of 0.7, indicating that its stock price is 30% less volatile than the S&P 500.
Analyst Recommendations
This is a summary of recent recommendations for Innovative Eyewear and SiBone, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Innovative Eyewear | 1 | 1 | 0 | 0 | 1.50 |
| SiBone | 1 | 0 | 6 | 0 | 2.71 |
SiBone has a consensus target price of $24.17, indicating a potential upside of 32.06%. Given SiBone’s stronger consensus rating and higher probable upside, analysts clearly believe SiBone is more favorable than Innovative Eyewear.
Summary
SiBone beats Innovative Eyewear on 11 of the 14 factors compared between the two stocks.
About Innovative Eyewear
Innovative Eyewear, Inc. develops and sells smart eyeglasses and sunglasses. The company's flagship product is Lucyd Lyte glasses that enable the wearer to listen to music, take and make calls, and use voice assistants to perform various smartphone tasks hands-free. It also offers Vyrb, a social media application that enables the user to receive and send posts through Lucyd Lyte smart glasses with voice. In addition, the company launches an application, Lucyd app for iOS/Android users. It sells its products through various e-commerce, and retail store and distribution channels. Innovative Eyewear, Inc. has a license agreement with Lucyd Ltd. The company was incorporated in 2019 and is headquartered in North Miami, Florida. Innovative Eyewear, Inc. is a subsidiary of Lucyd Ltd.
About SiBone
SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.
Receive News & Ratings for Innovative Eyewear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovative Eyewear and related companies with MarketBeat.com's FREE daily email newsletter.
